In conclusion, our meta-analysis indicates that the GSTP1 IIe105Val, GSTM1 and GSTT1 null or present genetic polymorphisms might be predictive factors for the efficacy of platinum-based chemotherapy to NSCLC patients. Here, GSTM1 is linked to non-small cell lung carcinoma.